Enhancement of Xanthine Dehydrogenase Mediated Mitomycin C Metabolism by Dicumarol

Cancer Research

Volumn 52, Issue 24, 1992, Pages 6936-6939

  Gustafson, Daniel L ^a   Pritsos, Chris A ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICOUMAROL; MITOMYCIN C; URIC ACID; XANTHINE DEHYDROGENASE;

AEROBIC METABOLISM; ARTICLE; DRUG ACTIVATION; DRUG METABOLISM; DRUG POTENTIATION; ENZYME INHIBITION; PRIORITY JOURNAL; REDUCTION;

ANIMAL; BIOTRANSFORMATION; DICUMAROL; MICE; MITOMYCIN; OXIDATION-REDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 0027052362     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Role of NADPH:cytochrome c reductase and DTdiaphorase in the biotransformation of mitomycin C. Cancer Res., 44: 5638-5643, 1984.
2. Keyes, S. R., Rockwell, S., and SartoreUi, A. C. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicumarol in vivo and in vitro. Cancer Res., 45: 213-216, 1985.
3. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res., 49: 3310-3313, 1989.
4. Marshall, R. S., Paterson, M. C., and Rauth, A. M. Deficient activation by a human cell strain leads to mitomycin C resistance under aerobic but not hypoxic conditions. Br. J. Cancer, 59: 341-346, 1989.
5. Dulhanty, A. M., and Whitmore, G. F. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. Cancer Res., 51: 1860-1865, 1991.
6. Begleiter, A., Robotham, E., and Leith, M. K. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol. Pharmacol., 41: 677-682, 1992.
7. Tomasz, M., Hughes, C. S., Chowdary, D., Keyes, S. R., Lipman, R., Sartorelli, A. C., and Rockwell, S. Isolation, identification, and assay of [3H]--porfiromycin adducts of EMT6 mouse mammary cell DNA: effects of hypoxia and dicumarol on adduct patterns. Cancer Commun., 3: 213-223, 1991.
8. Gustafson, D. L., and Pritsos, C. A. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst., 84: 1180-1185, 1992.
9. Gustafson, D. L., and Pritsos, C. A. Oxygen radical generation and alkylating ability of mitomycin C bioactivated by xanthine dehydrogenase. Proc. West. Pharmacol. Soc., 35: 147-151, 1992.
10. Suleiman, S. A., and Stevens, J. B. Purification of xanthine dehydrogenase from rat liver: a rapid procedure with high enzyme yields. Arch. Biochem. Biophys., 258: 219-225, 1987.
11. Stirpe, F., and Della Corte, E. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J. Biol. Chem., 244: 3855-3863, 1969.
12. Pan, S., Andrews, P. A., Glover, C. J., and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem., 259: 959-966, 1984.
13. Siegel, D., Gibson, N. W., Preusch, P. C., and Ross, D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7483-7489, 1990.
14. Begleiter, A., Leith, M., McClarty, G., Beenken, S., Goldenberg, G. J., and Wright, J. A. Characterization of L5178Y murine lymphoblasts resistant to quinone anticancer agents. Cancer Res., 48: 1727-1735, 1988.